Abstract
Since recent data suggest that the endocannabinoid system controls food intake through central, and lipogenesis via peripheral CB1 receptors, we hypothesized that genetic variation at the cannabinoid receptor-1 (CNR1) locus could have an effect on adiposity. We investigated, whether a specific CNR1 G1422A genotype is associated with anthropometric markers of obesity and fat distribution in adult obese individuals. A total of 1,064 obese subjects (BMI ≥ 30 kg/m2) without diabetes, impaired glucose tolerance or other endocrine diseases and 251 healthy control persons were genotyped for the G1422A variant (rs1049353) with a TaqMan assay. Anthropometric measures as body weight, BMI, waist and waist-to-hip ratio (WHR) were assessed by classical methods. Fat mass (FM) was measured by bio-impedance. The prevalence of the G1422A variant was not significantly different between cases and controls (OR = 1.056; P = 0.626). In obese women, no meaningful associations between CNR1 genotype and anthropometric parameters were found. In obese men, CNR1 1422 A/A genotype was significantly associated with higher WHR (P = 0.009) and waist circumference (P = 0.008) after adjusting for age and BMI. Fat mass percentage showed an association (P = 0.011) which disappeared after adjusting for age and BMI. A trend for an association was seen for fat mass (unadjusted P = 0.099; adjusted P = 0.033). Our data indicate that the G1422A polymorphism in the CNR1 gene is associated with increased abdominal adiposity in obese men.
Similar content being viewed by others
References
L. Van Gaal, I. Mertens, C. De Block, Nature 444, 875 (2006)
D. Cota, G. Marsicano, M. Tschop, Y. Grubler, C. Flachskamm, M. Schubert, D. Auer, A. Yassouridis, C. Thone-Reineke, S. Ortmann, F. Tomassoni, C. Cervino, E. Nisoli, A.C. Linthorst, R. Pasquali, B. Lutz, G.K. Stalla, U. Pagotto, J. Clin. Invest. 112, 423 (2003)
S. Engeli, J. Bohnke, M. Feldpausch, K. Gorzelniak, J. Janke, S. Batkai, P. Pacher, J. Harvey-White, F.C. Luft, A.M. Sharma, J. Jordan, Diabetes 54, 2838 (2005)
U. Pagotto, G. Marsicano, D. Cota, B. Lutz, R. Pasquali, Endocr. Rev. 27, 73 (2006)
L.F. Van Gaal, A.M. Rissanen, A.J. Scheen, O. Ziegler, S. Rossner, Lancet 365, 1389 (2005)
J.C. Sipe, J. Waalen, A. Gerber, E. Beutler, Int. J. Obes. (Lond) 29, 755 (2005)
D. Gadzicki, K. Muller-Vahl, M. Stuhrmann, Mol. Cell. Probes 13, 321 (1999)
N. Geary, Physiol. Behav. 83, 659 (2004)
P. Arner, Int. J. Obes. Relat. Metab. Disord. 24 Suppl 4, S57 (2000)
J. Duan, M.S. Wainwright, J.M. Comeron, N. Saitou, A.R. Sanders, J. Gelernter, P.V. Gejman, Hum. Mol. Genet. 12, 205 (2003)
R. Roche, L. Hoareau, S. Bes-Houtmann, M.P. Gonthier, C. Laborde, J.F. Baron, Y. Haffaf, M. Cesari, F. Festy, Histochem. Cell. Biol. 126, 177 (2006)
D. Osei-Hyiaman, M. DePetrillo, P. Pacher, J. Liu, S. Radaeva, S. Batkai, J. Harvey-White, K. Mackie, L. Offertaler, L. Wang, G. Kunos, J. Clin. Invest. 115, 1298 (2005)
K.G. Alberti, P.Z. Zimmet, Diabet. Med. 15, 539 (1998)
R.A. DeFronzo, E. Ferrannini, Diabetes Care 14, 173 (1991)
P. Deurenberg, J.A. Weststrate, J.G. Hautvast, Am. J. Clin. Nutr. 49, 33 (1989)
T.M. Strom, W.F. Wienker, Case control studies: Tests for deviation from Hardy–Weinberg equilibrium and tests for association. Available from http://ihg.gsf.de/cgi-bin/hw/hwa1.pl; accessed 7 May 2007
Acknowledgments
We thank J. Vertommen, M. Vinckx and P. Aerts for sampling handling. Financial support to this study was provided by the University of Antwerp (NOI-BOF grant) and the Fund for Scientific Research (FWO) Flanders (research project) both to LVG and WVH. SB holds a predoctoral research grant from the Instituut voor de aanmoediging van innovatie door Wetenschap en Technologie (IWT) in Vlaanderen. The authors do not report any conflict of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peeters, A., Beckers, S., Mertens, I. et al. The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men. Endocr 31, 138–141 (2007). https://doi.org/10.1007/s12020-007-0022-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-007-0022-y